Newtyn Management’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,446
| Closed | -$304K | – | 35 |
|
|
2024
Q3 | $304K | Sell |
23,446
-44,716
| -66% | -$580K | 0.05% | 39 |
|
|
2024
Q2 | $1.02M | Sell |
68,162
-16,838
| -20% | -$253K | 0.19% | 35 |
|
|
2024
Q1 | $2.38M | Buy |
85,000
+7,323
| +9% | +$205K | 0.47% | 29 |
|
|
2023
Q4 | $1.74M | Buy |
77,677
+26,677
| +52% | +$598K | 0.34% | 33 |
|
|
2023
Q3 | $1.06M | Buy |
51,000
+1,000
| +2% | +$20.8K | 0.26% | 38 |
|
|
2023
Q2 | $1.28M | Sell |
50,000
-5,756
| -10% | -$147K | 0.3% | 35 |
|
|
2023
Q1 | $1.55M | Sell |
55,756
-1,744
| -3% | -$48.5K | 0.3% | 52 |
|
|
2022
Q4 | $1.5M | Buy |
57,500
+27,500
| +92% | +$715K | 0.31% | 42 |
|
|
2022
Q3 | $888K | Sell |
30,000
-7,413
| -20% | -$219K | 0.2% | 58 |
|
|
2022
Q2 | $1.53M | Buy |
+37,413
| New | +$1.53M | 0.29% | 50 |
|